insights_auto
Proč je 500124 níž 2,06%?
Prozkoumat hloubějichevron_right
500124:BOM
Dr Reddy's Laboratories Ltd
1 214,10 INR
arrow_downward
-2,06%(-25,55) 1D
14. 10., 15:30:00 GMT+5:30 · INR
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro 500124…
Otevřít
1 237,35 INR
Max.
1 237,35 INR
Min.
1 209,65 INR
Trž. kap.
1,01 bil.
Prům. obj.
85,80 tis.
Objem
43,85 tis.
Dividenda
0,66 %
Čtvrtletní dividenda
2,00 INR
Datum ex dividenda
10. 7. 2026
Ukazatel P/E
31,40
52týd. max.
1 414,40 INR
52týd. min.
1 080,05 INR
EPS
38,67 INR
Akcie v oběhu
166,06 mil.
Počet zaměstnanců
28 tis.
Otevřít
1 237,35 INR
Max.
1 237,35 INR
Min.
1 209,65 INR
Trž. kap.
1,01 bil.
Prům. obj.
85,80 tis.
Objem
43,85 tis.
Dividenda
0,66 %
Čtvrtletní dividenda
2,00 INR
Datum ex dividenda
10. 7. 2026
Ukazatel P/E
31,40
52týd. max.
1 414,40 INR
52týd. min.
1 080,05 INR
EPS
38,67 INR
Akcie v oběhu
166,06 mil.
Počet zaměstnanců
28 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
www.marketscreener.com
·
před 1 dnem
Dr. Reddy's Laboratories Shares Rise After BNP Paribas Upgrade
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Informace o Dr Reddy's Laboratories Ltd
Generální ředitelErez Israeli
Zaměstnanci27,5 tis.
Založeno1984
ÚstředíHaidarábád, Andhrapradéš, Indie
Odvětví-
Webdrreddys.com